All blog posts
Total 27 results for
Showing 12 out of 27 results
19 十一月 2024
Sustainability - trends and developments life sciences companies should be aware of
01 十一月 2024
EU Commission fines Teva €462.6 million for misuse of divisional patents and disparagement campaign
11 十月 2024
The new UK Regulatory Innovation Office – a step in the right direction for UK life sciences
04 九月 2024
CJEU finds EC's recent policy of referrals for deals below the merger thresholds illegal - more certainty for companies doing deals?
15 八月 2024
H1 2024 – a steady start for biopharma M&A
07 八月 2024
A new Labour Government – what might this mean for the UK life sciences industry?
01 八月 2024
The EU AI Act Is In Force From Today (1 August 2024)
29 七月 2024
Commission investigation into anticompetitive disparagement ends with commitments
23 七月 2024
UPC finds Edwards' patent valid (as amended) – Meril's revocations dismissed
16 七月 2024
UPC revokes Amgen's patent in the first case filed at the UPC
12 七月 2024
The EU focuses its Industrial Policy on Critical Industries - STEP Regulation solidifies Biotechnology focus
11 七月 2024
EU FRAND regulation – what next for FRAND litigation in Europe?
Showing 12 out of 27 results
View moreKey contacts
Laura Orlando
Managing Partner, Milan Office, Milan
Alan Montgomery
Partner, Head of Pharmaceuticals Sector, Chair of India Group, London and India Group
Chris Parker KC
Partner, Head of Pharmaceuticals Sector, London and Africa Group